[go: up one dir, main page]

Babich et al., 2021 - Google Patents

Study of the in vitro degradation dynamics of the encapsulated PAL enzyme preparation in model biological fluids

Babich et al., 2021

View PDF
Document ID
8361900320195063844
Author
Babich O
Prosekov A
Dyshlyuk L
Publication year
Publication venue
IOP Conference Series: Earth and Environmental Science

External Links

Snippet

The use of PAL in the phenylketonuria treatment is hindered by the lack of well-studied mechanisms and systems of targeted transport of enzyme preparations to certain organs and tissues (brain, liver, skin, muscle and connective tissues, blood cells). It is known that as …
Continue reading at iopscience.iop.org (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30Macromolecular compounds
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Du et al. A study on the preparation of chitosan-tripolyphosphate nanoparticles and its entrapment mechanism for egg white derived peptides
Ebrahimnejad et al. Survival of Lactobacillus acidophilus as probiotic bacteria using chitosan nanoparticles
US20050226905A1 (en) Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protection
EP0321481B1 (en) Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
KR20050083758A (en) Composition exhibiting stabilised oxidation-reduction properties and method for the stabilisation thereof
BR0207398B1 (en) Use of bacteria and yeast for biological detoxification of ochratoxins and zearalenons mycotoxins in food and animal feed, as well as detoxification method of said mycotoxins.
Deng et al. Tea polyphenol liposomes overcome gastric mucus to treat Helicobacter pylori infection and enhance the intestinal microenvironment
CN104338112B (en) A kind of preparation method of glutathione nano controlled-release capsule
JP2003002840A (en) Cucumismelo extract coated and / or microencapsulated in a fat-soluble agent based on fatty substances
Zhang et al. Carboxymethyl cellulose and carboxymethyl chitosan-based composite nanogel as a stable delivery vehicle for oyster peptides: Characterization, absorption and transport mechanism
Babich et al. Study of the in vitro degradation dynamics of the encapsulated PAL enzyme preparation in model biological fluids
Cui et al. Acute and chronic toxicity assessment of benzylpenicillin G residue in heat-treated animal food products
US12215360B2 (en) Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith
JP2020183351A (en) Anaerobic antioxidant composition
RU45270U1 (en) DRY FORM OF BIOLOGICALLY ACTIVE ADDITIVE BASED ON ARTEMIA SALINA
CA3041914C (en) Anaerobic antioxidant composition
WO2008068762A2 (en) Chitosan formulation for cholesterol reduction in humans
RU2316978C2 (en) Dry form of biologically active food supplement based on artemia salina maxillopod cysts (variants)
EP1171103B1 (en) Inactivated microorganisms comprising substances having pharmacological activity
WO2021030785A1 (en) Method for the preparation of low molecular weight porcine lympho-reticular polypeptides and formulations thereof
CN110339169A (en) Coat nano vesicle preparations and its application of vitamin D and vitamin K
WO2025055959A1 (en) Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith
CN116158534B (en) High-load and stable protein liposome
RU2828677C1 (en) Agent for dietary therapeutic alimentation
WO1999022768A1 (en) Controlled release compositions comprising gellan gum gels